Post by Renata Collazo, MS, MBA

Global Business Development- Cell & Gene, mRNA, Microbial (Specialized Modalities Platform)

A great perspective on how microbial manufacturing is evolving to meet the growing demands of today's biologics market. In this Q&A, Axel Erler shares insights on increasing process complexity, the need for more flexible and scalable manufacturing platforms, and how innovation is helping accelerate development while improving efficiency and consistency.

Post content